GMAB
Genmab AS
35.60$
+0.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.49 | 1.86 | 2.94 | 3.81 | 4.88 | 8.43 | 15.35 | 12.74 | 21.97 | 24.99 | 33.30 | 5.94 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.34 | 1.52 | 0.49 | |
| 1.49 | 1.86 | 2.94 | 3.81 | 4.88 | 8.43 | 15.35 | 12.74 | 21.97 | 24.65 | 31.78 | 5.45 | |
| 0.88 | 0.80 | 1.07 | 1.41 | 2.31 | 3.75 | 4.76 | 6.33 | 8.43 | 11.58 | 15.08 | 2.49 | |
| 0.14 | 0.15 | 0.17 | 0.24 | 0.34 | 0.54 | 1.00 | 1.94 | 4.05 | 5.00 | 5.86 | 1.00 | |
| 1.02 | 0.66 | 1.24 | 1.64 | 2.65 | 4.29 | 5.76 | 8.27 | 12.48 | 16.58 | 21.41 | 3.45 | |
| 0.46 | 1.20 | 1.70 | 2.16 | 2.22 | 4.15 | 9.58 | 4.47 | 9.49 | 8.07 | 10.37 | 2.00 | |
| 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 0.19 | 0.10 | |
| 0.52 | 1.25 | 1.83 | 1.71 | 2.60 | 4.49 | 8.96 | 5.93 | 10.52 | 8.55 | 14.18 | 1.92 | |
| -0.01 | -0.01 | -0.09 | -0.06 | 0.23 | 1.09 | 1.74 | 1.46 | 2.26 | 1.95 | 2.04 | 0.38 | |
| 0.53 | 1.26 | 1.92 | 1.78 | 2.37 | 3.40 | 7.22 | 4.48 | 8.26 | 6.60 | 12.14 | 1.54 | |
| 0.55 | 1.30 | 1.90 | 2.40 | 2.74 | 4.72 | 9.35 | 6.33 | 11.13 | 9.02 | 15.00 | 2.13 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.